# Nvidia Corp: financial statements, quarterly

NVDA · Nasdaq · CIK 1045810 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/nvda.md) · [Financials](/companies/nvda/financials.md) · [Filings](/companies/nvda/filings.md) · [Insiders](/companies/nvda/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nvda/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-29) | Q4 FY2024 (2024-01-28) | Q1 FY2025 (2024-04-28) | Q2 FY2025 (2024-07-28) | Q3 FY2025 (2024-10-27) | Q4 FY2025 (2025-01-26) | Q1 FY2026 (2025-04-27) | Q2 FY2026 (2025-07-27) | Q3 FY2026 (2025-10-26) | Q4 FY2026 (2026-01-25) | Q1 FY2027 (2026-04-26) | Q2 FY2027 (2026-07-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [18.1](/filings/0001045810-24-000316.md) | [22.1 d](/filings/0001045810-26-000021.md) | [26.0](/filings/0001045810-25-000116.md) | [30.0](/filings/0001045810-25-000209.md) | [35.1](/filings/0001045810-25-000230.md) | [39.3 d](/filings/0001045810-26-000021.md) | [44.1](/filings/0001045810-26-000052.md) | [46.7](/filings/0001045810-26-000075.md) | [57.0](/filings/0001045810-25-000230.md) | [68.1 d](/filings/0001045810-26-000021.md) | [81.6](/filings/0001045810-26-000052.md) | [96.2](/filings/0001045810-26-000075.md) |
| Cost of revenue | $bn | [4.7](/filings/0001045810-24-000316.md) | [5.3 d](/filings/0001045810-26-000021.md) | [5.6](/filings/0001045810-25-000116.md) | [7.5](/filings/0001045810-25-000209.md) | [8.9](/filings/0001045810-25-000230.md) | [10.6 d](/filings/0001045810-26-000021.md) | [17.4](/filings/0001045810-26-000052.md) | [12.9](/filings/0001045810-26-000075.md) | [15.2](/filings/0001045810-25-000230.md) | [17.0 d](/filings/0001045810-26-000021.md) | [20.5](/filings/0001045810-26-000052.md) | [24.1](/filings/0001045810-26-000075.md) |
| Gross profit | $bn | [13.4](/filings/0001045810-24-000316.md) | [16.8 d](/filings/0001045810-26-000021.md) | [20.4](/filings/0001045810-25-000116.md) | [22.6](/filings/0001045810-25-000209.md) | [26.2](/filings/0001045810-25-000230.md) | [28.7 d](/filings/0001045810-26-000021.md) | [26.7](/filings/0001045810-26-000052.md) | [33.9](/filings/0001045810-26-000075.md) | [41.8](/filings/0001045810-25-000230.md) | [51.1 d](/filings/0001045810-26-000021.md) | [61.2](/filings/0001045810-26-000052.md) | [72.1](/filings/0001045810-26-000075.md) |
| Research and development | $bn | [2.3](/filings/0001045810-24-000316.md) | [2.5 d](/filings/0001045810-26-000021.md) | [2.7](/filings/0001045810-25-000116.md) | [3.1](/filings/0001045810-25-000209.md) | [3.4](/filings/0001045810-25-000230.md) | [3.7 d](/filings/0001045810-26-000021.md) | [4.0](/filings/0001045810-26-000052.md) | [4.3](/filings/0001045810-26-000075.md) | [4.7](/filings/0001045810-25-000230.md) | [5.5 d](/filings/0001045810-26-000021.md) | [6.3](/filings/0001045810-26-000052.md) | [7.1](/filings/0001045810-26-000075.md) |
| Selling, general and administrative | $bn | [0.7](/filings/0001045810-24-000316.md) | [0.7 d](/filings/0001045810-26-000021.md) | [0.8](/filings/0001045810-25-000116.md) | [0.8](/filings/0001045810-25-000209.md) | [0.9](/filings/0001045810-25-000230.md) | [1.0 d](/filings/0001045810-26-000021.md) | [1.0](/filings/0001045810-26-000052.md) | [1.1](/filings/0001045810-26-000075.md) | [1.1](/filings/0001045810-25-000230.md) | [1.3 d](/filings/0001045810-26-000021.md) | [1.3](/filings/0001045810-26-000052.md) | [1.4](/filings/0001045810-26-000075.md) |
| Operating income | $bn | [10.4](/filings/0001045810-24-000316.md) | [13.6 d](/filings/0001045810-26-000021.md) | [16.9](/filings/0001045810-25-000116.md) | [18.6](/filings/0001045810-25-000209.md) | [21.9](/filings/0001045810-25-000230.md) | [24.0 d](/filings/0001045810-26-000021.md) | [21.6](/filings/0001045810-26-000052.md) | [28.4](/filings/0001045810-26-000075.md) | [36.0](/filings/0001045810-25-000230.md) | [44.3 d](/filings/0001045810-26-000021.md) | [53.5](/filings/0001045810-26-000052.md) | [63.7](/filings/0001045810-26-000075.md) |
| Interest expense | $bn | [0.1](/filings/0001045810-23-000227.md) | [0.1 d](/filings/0001045810-24-000029.md) | [0.1](/filings/0001045810-24-000124.md) | [0.1](/filings/0001045810-25-000209.md) | [0.1](/filings/0001045810-25-000230.md) | [0.1 d](/filings/0001045810-26-000021.md) | [0.1](/filings/0001045810-26-000052.md) | [0.1](/filings/0001045810-26-000075.md) | [0.1](/filings/0001045810-25-000230.md) | [0.1 d](/filings/0001045810-26-000021.md) | [0.1](/filings/0001045810-26-000052.md) | [0.2](/filings/0001045810-26-000075.md) |
| Income tax | $bn | [1.3](/filings/0001045810-24-000316.md) | [1.8 d](/filings/0001045810-26-000021.md) | [2.4](/filings/0001045810-25-000116.md) | [2.6](/filings/0001045810-25-000209.md) | [3.0](/filings/0001045810-25-000230.md) | [3.1 d](/filings/0001045810-26-000021.md) | [3.1](/filings/0001045810-26-000052.md) | [4.8](/filings/0001045810-26-000075.md) | [6.0](/filings/0001045810-25-000230.md) | [7.4 d](/filings/0001045810-26-000021.md) | [11.6](/filings/0001045810-26-000052.md) | [11.8](/filings/0001045810-26-000075.md) |
| Net income | $bn | [9.2](/filings/0001045810-24-000316.md) | [12.3 d](/filings/0001045810-26-000021.md) | [14.9](/filings/0001045810-25-000116.md) | [16.6](/filings/0001045810-25-000209.md) | [19.3](/filings/0001045810-25-000230.md) | [22.1 d](/filings/0001045810-26-000021.md) | [18.8](/filings/0001045810-26-000052.md) | [26.4](/filings/0001045810-26-000075.md) | [31.9](/filings/0001045810-25-000230.md) | [43.0 d](/filings/0001045810-26-000021.md) | [58.3](/filings/0001045810-26-000052.md) | [59.7](/filings/0001045810-26-000075.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001045810-24-000316.md) | not reported | [0.60](/filings/0001045810-25-000116.md) | [0.67](/filings/0001045810-25-000209.md) | [0.78](/filings/0001045810-25-000230.md) | not reported | [0.76](/filings/0001045810-26-000052.md) | [1.08](/filings/0001045810-26-000075.md) | [1.30](/filings/0001045810-25-000230.md) | not reported | [2.39](/filings/0001045810-26-000052.md) | [2.46](/filings/0001045810-26-000075.md) |
| Basic EPS | $ per share | [0.37](/filings/0001045810-24-000316.md) | not reported | [0.60](/filings/0001045810-25-000116.md) | [0.68](/filings/0001045810-25-000209.md) | [0.79](/filings/0001045810-25-000230.md) | not reported | [0.77](/filings/0001045810-26-000052.md) | [1.08](/filings/0001045810-26-000075.md) | [1.31](/filings/0001045810-25-000230.md) | not reported | [2.40](/filings/0001045810-26-000052.md) | [2.47](/filings/0001045810-26-000075.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-29) | FY2024 (2024-01-28) | Q1 FY2025 (2024-04-28) | Q2 FY2025 (2024-07-28) | Q3 FY2025 (2024-10-27) | FY2025 (2025-01-26) | Q1 FY2026 (2025-04-27) | Q2 FY2026 (2025-07-27) | Q3 FY2026 (2025-10-26) | FY2026 (2026-01-25) | Q1 FY2027 (2026-04-26) | Q2 FY2027 (2026-07-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.5](/filings/0001045810-23-000227.md) | [7.3](/filings/0001045810-25-000023.md) | [7.6](/filings/0001045810-24-000124.md) | [8.6](/filings/0001045810-24-000264.md) | [9.1](/filings/0001045810-24-000316.md) | [8.6](/filings/0001045810-26-000021.md) | [15.2](/filings/0001045810-25-000116.md) | [11.6](/filings/0001045810-25-000209.md) | [11.5](/filings/0001045810-25-000230.md) | [10.6](/filings/0001045810-26-000075.md) | [13.2](/filings/0001045810-26-000052.md) | [22.4](/filings/0001045810-26-000075.md) |
| Current assets | $bn | [32.7](/filings/0001045810-23-000227.md) | [44.3](/filings/0001045810-25-000023.md) | [53.7](/filings/0001045810-24-000124.md) | [59.6](/filings/0001045810-24-000264.md) | [67.6](/filings/0001045810-24-000316.md) | [80.1](/filings/0001045810-26-000021.md) | [89.9](/filings/0001045810-25-000116.md) | [102](/filings/0001045810-25-000209.md) | [116](/filings/0001045810-25-000230.md) | [126](/filings/0001045810-26-000075.md) | [151](/filings/0001045810-26-000052.md) | [197](/filings/0001045810-26-000075.md) |
| Total assets | $bn | [54.1](/filings/0001045810-23-000227.md) | [65.7](/filings/0001045810-25-000023.md) | [77.1](/filings/0001045810-24-000124.md) | [85.2](/filings/0001045810-24-000264.md) | [96.0](/filings/0001045810-24-000316.md) | [112](/filings/0001045810-26-000021.md) | [125](/filings/0001045810-25-000116.md) | [141](/filings/0001045810-25-000209.md) | [161](/filings/0001045810-25-000230.md) | [207](/filings/0001045810-26-000075.md) | [259](/filings/0001045810-26-000052.md) | [320](/filings/0001045810-26-000075.md) |
| Current liabilities | $bn | [9.1](/filings/0001045810-23-000227.md) | [10.6](/filings/0001045810-25-000023.md) | [15.2](/filings/0001045810-24-000124.md) | [14.0](/filings/0001045810-24-000264.md) | [16.5](/filings/0001045810-24-000316.md) | [18.0](/filings/0001045810-26-000021.md) | [26.5](/filings/0001045810-25-000116.md) | [24.3](/filings/0001045810-25-000209.md) | [26.1](/filings/0001045810-25-000230.md) | [32.2](/filings/0001045810-26-000075.md) | [43.9](/filings/0001045810-26-000052.md) | [43.0](/filings/0001045810-26-000075.md) |
| Total liabilities | $bn | [20.9](/filings/0001045810-23-000227.md) | [22.8](/filings/0001045810-25-000023.md) | [27.9](/filings/0001045810-24-000124.md) | [27.1](/filings/0001045810-24-000264.md) | [30.1](/filings/0001045810-24-000316.md) | [32.3](/filings/0001045810-26-000021.md) | [41.4](/filings/0001045810-25-000116.md) | [40.6](/filings/0001045810-25-000209.md) | [42.3](/filings/0001045810-25-000230.md) | [49.5](/filings/0001045810-26-000075.md) | [64.0](/filings/0001045810-26-000052.md) | [91.3](/filings/0001045810-26-000075.md) |
| Long-term debt | $bn | [8.5](/filings/0001045810-23-000227.md) | [8.5](/filings/0001045810-25-000023.md) | [8.5](/filings/0001045810-24-000124.md) | [8.5](/filings/0001045810-24-000264.md) | [8.5](/filings/0001045810-24-000316.md) | [8.5](/filings/0001045810-26-000021.md) | [8.5](/filings/0001045810-25-000116.md) | [8.5](/filings/0001045810-25-000209.md) | [7.5](/filings/0001045810-25-000230.md) | [7.5](/filings/0001045810-26-000075.md) | [7.5](/filings/0001045810-26-000052.md) | [32.4](/filings/0001045810-26-000075.md) |
| Current portion of debt | $bn | [1.2](/filings/0001045810-23-000227.md) | [1.3](/filings/0001045810-25-000023.md) | [1.3](/filings/0001045810-24-000124.md) | [0.0](/filings/0001045810-24-000264.md) | [0.0](/filings/0001045810-24-000316.md) | [0.0](/filings/0001045810-26-000021.md) | not reported | not reported | [1.0](/filings/0001045810-25-000230.md) | [1.0](/filings/0001045810-26-000075.md) | [1.0](/filings/0001045810-26-000052.md) | [1.0](/filings/0001045810-26-000075.md) |
| Short-term borrowings | $bn | not reported | [0.0](/filings/0001045810-24-000029.md) | not reported | not reported | not reported | [0.0](/filings/0001045810-25-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [33.3](/filings/0001045810-24-000316.md) | [43.0](/filings/0001045810-26-000021.md) | [49.1](/filings/0001045810-25-000209.md) | [58.2](/filings/0001045810-25-000230.md) | [65.9](/filings/0001045810-25-000230.md) | [79.3](/filings/0001045810-26-000075.md) | [83.8](/filings/0001045810-26-000075.md) | [100](/filings/0001045810-26-000075.md) | [119](/filings/0001045810-25-000230.md) | [157](/filings/0001045810-26-000075.md) | [195](/filings/0001045810-26-000075.md) | [229](/filings/0001045810-26-000075.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-29) | Q4 FY2024 (2024-01-28) | Q1 FY2025 (2024-04-28) | Q2 FY2025 (2024-07-28) | Q3 FY2025 (2024-10-27) | Q4 FY2025 (2025-01-26) | Q1 FY2026 (2025-04-27) | Q2 FY2026 (2025-07-27) | Q3 FY2026 (2025-10-26) | Q4 FY2026 (2026-01-25) | Q1 FY2027 (2026-04-26) | Q2 FY2027 (2026-07-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [7.3 d](/filings/0001045810-24-000316.md) | [11.5 d](/filings/0001045810-26-000021.md) | [15.3](/filings/0001045810-25-000116.md) | [14.5 d](/filings/0001045810-25-000209.md) | [17.6 d](/filings/0001045810-25-000230.md) | [16.6 d](/filings/0001045810-26-000021.md) | [27.4](/filings/0001045810-26-000052.md) | [15.4 d](/filings/0001045810-26-000075.md) | [23.8 d](/filings/0001045810-25-000230.md) | [36.2 d](/filings/0001045810-26-000021.md) | [50.3](/filings/0001045810-26-000052.md) | [24.1 d](/filings/0001045810-26-000075.md) |
| Capital expenditure | $bn | [0.3 d](/filings/0001045810-24-000316.md) | [0.3 d](/filings/0001045810-26-000021.md) | [0.4](/filings/0001045810-25-000116.md) | [1.0 d](/filings/0001045810-25-000209.md) | [0.8 d](/filings/0001045810-25-000230.md) | [1.1 d](/filings/0001045810-26-000021.md) | [1.2](/filings/0001045810-26-000052.md) | [1.9 d](/filings/0001045810-26-000075.md) | [1.6 d](/filings/0001045810-25-000230.md) | [1.3 d](/filings/0001045810-26-000021.md) | [1.8](/filings/0001045810-26-000052.md) | [2.7 d](/filings/0001045810-26-000075.md) |
| Dividends paid | $bn | [0.1](/filings/0001045810-24-000316.md) | [0.1 d](/filings/0001045810-26-000021.md) | [0.1](/filings/0001045810-25-000116.md) | [0.2](/filings/0001045810-25-000209.md) | [0.2](/filings/0001045810-24-000316.md) | [0.2 d](/filings/0001045810-26-000021.md) | [0.2](/filings/0001045810-26-000052.md) | [0.2](/filings/0001045810-26-000075.md) | [0.2 d](/filings/0001045810-25-000230.md) | [0.2 d](/filings/0001045810-26-000021.md) | [0.2](/filings/0001045810-26-000052.md) | [6.0](/filings/0001045810-26-000075.md) |
| Share repurchases | $bn | [3.8 d](/filings/0001045810-24-000316.md) | [2.7 d](/filings/0001045810-26-000021.md) | [7.7](/filings/0001045810-25-000116.md) | [7.2 d](/filings/0001045810-25-000209.md) | [11.0 d](/filings/0001045810-25-000230.md) | [7.8 d](/filings/0001045810-26-000021.md) | [14.1](/filings/0001045810-26-000052.md) | [9.7 d](/filings/0001045810-26-000075.md) | [12.5 d](/filings/0001045810-25-000230.md) | [3.8 d](/filings/0001045810-26-000021.md) | [19.3](/filings/0001045810-26-000052.md) | [19.7 d](/filings/0001045810-26-000075.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-30) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-30) | Q3 FY2024 (2023-10-29) | Q1 FY2025 (2024-04-28) | Q2 FY2025 (2024-07-28) | Q3 FY2025 (2024-10-27) | Q1 FY2026 (2025-04-27) | Q2 FY2026 (2025-07-27) | Q3 FY2026 (2025-10-26) | Q1 FY2027 (2026-04-26) | Q2 FY2027 (2026-07-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [2.5](/filings/0001045810-23-000227.md) | [2.5](/filings/0001045810-24-000124.md) | [25.0](/filings/0001045810-24-000264.md) | [24.9](/filings/0001045810-24-000316.md) | [24.9](/filings/0001045810-25-000116.md) | [24.8](/filings/0001045810-25-000209.md) | [24.8](/filings/0001045810-25-000230.md) | [24.6](/filings/0001045810-26-000052.md) | [24.5](/filings/0001045810-26-000075.md) | [24.5](/filings/0001045810-25-000230.md) | [24.4](/filings/0001045810-26-000052.md) | [24.3](/filings/0001045810-26-000075.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,100,000,000 at 2026-08-21, from the cover of the [10-Q filed 2026-08-26](/filings/0001045810-26-000075.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.